Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs

Journal of Clinical Microbiology

Volumn 44, Issue 9, 2006, Pages 3381-3383

  Forrest, G N ^a   Mankes, K ^a   Jabra Rizk, M A ^a,b   Weekes, E ^c   Johnson, J K ^a   Lincalis, D P ^a   Venezia, R A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^c UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; PEPTIDE NUCLEIC ACID;

ARTICLE; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDIASIS; COST CONTROL; DRUG COST; DRUG DOSE REGIMEN; EARLY DIAGNOSIS; FLUORESCENCE IN SITU HYBRIDIZATION; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; PEPTIDE NUCLEIC ACID FLUORESCENCE IN SITU HYBRIDIZATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; FUNGEMIA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MYCOLOGICAL TYPING TECHNIQUES; PEPTIDE NUCLEIC ACIDS; PEPTIDES, CYCLIC; SENSITIVITY AND SPECIFICITY;

CANDIDA ALBICANS;

EID: 33748791771     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00751-06     Document Type: Article

References (12)

1. Alexander, B. D., E. D. Ashley, L. B. Reller, and S. D. Reed. 2006. Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures. Diagn. Microbiol. Infect. Dis. 54:277-282.
2. Cuenca-Estrella, M., W. Lee-Yang, M. A. Ciblak, B. A. Arthington-Skaggs, E. Mellado, D. W. Warnock, and J. L. Rodriguez-Tudela. Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of Candida species. Antimicrob. Agents Chemother. 46:3644-3647.
3. Jabra-Rizk, M. A., J. K. Johnson, G. Forrest, K. Mankes, T. F. Meiller, and R. A. Venezia. 2005. Prevalence of Candida dubliniensis fungemia at a large teaching hospital. Clin. Infect. Dis. 41:1064-1067.
4. NCCLS. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard M27-A. NCCLS, Wayne, Pa.
5. Oliveira, K., G. Haase, C. Kurtzman, J. J. Hyldig-Nielsen, and H. Stender. 2001. Differentiation of Candida albicans and Candida dubliniensis by fluorescent in situ hybridization with peptide nucleic acid probes. J. Clin. Microbiol. 39:4138-4141.
6. Pfaller, M. A. 2005. Antifungal susceptibility testing methods. Curr. Drug Targets 6:929-943.
7. Pfaller, M. A., D. J. Diekema, M. G. Rinaldi, R. Barnes, B. Hu, A. V. Veselov, N. Tiraboschi, E. Nagy, D. L. Gibbs, and the Global Antifungal Surveillance Group. 2005. Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing. J. Clin. Microbiol. 43:5848-5859.
8. Pfaller, M. A., S. A. Messer, L. Boyken, S. Tendolkar, R. J. Hollis, and D. J. Diekema. 2003. Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location. J. Clin. Microbiol. 41:2176-2179.
9. Rigby, S., G. W. Procop, G. Haase, D. Wilson, G. Hall, C. Kurtzman, K. Oliveira, S. Von Oy, J. J. Hyldig-Nielsen, J. Coull, and H. Stender. 2002. Fluorescence in situ hybridization with peptide nucleic acid probes for rapid identification of Candida albicans directly from blood culture bottles. J. Clin. Microbiol. 40:2182-2186.
10. Sutton, D. A. 2003. Specimen collection, transport, and processing: mycology, p. 1659-1667. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.), Manual of clinical microbiology. ASM Press, Washington, D.C.
11. WHO Collaborating Centre for Drug Statistics Methodology. 1996. Guidelines for ATC classification and DDD assignment. WHO Collaborating Centre for Drug Statistics Methodology, Oslo, Norway.
12. Wilson, D. A., M. J. Joyce, L. S. Hall, L. B. Reller, G. D. Roberts, G. S. Hall, B. D. Alexander, and G. W. Procop. 2005. Multicenter evaluation of a Candida albicans peptide nucleic acid fluorescent in situ hybridization probe for characterization of yeast isolates from blood cultures. J. Clin. Microbiol. 43:2909-2912.